Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 46

Results For "science"

2103 News Found

Feinstein Institutes awarded $3.37 million grant to boost first responder mental health
R&D | December 01, 2025

Feinstein Institutes awarded $3.37 million grant to boost first responder mental health

The study, titled “A Large-Scale Efficacy Trial of a Resilience Training Program for First Responders,” will enroll 800 first responders in New York and Texas


Granules India opens advanced Centres of Excellence in Hyderabad
R&D | December 01, 2025

Granules India opens advanced Centres of Excellence in Hyderabad

Ascelis Center of Excellence for Peptide Development and Characterization will drive the development of cosmetic, therapeutic, and pharmaceutical peptides


Akums Drugs appoints Yuvraj Datta as President – Operational Strategy & Excellence
People | November 28, 2025

Akums Drugs appoints Yuvraj Datta as President – Operational Strategy & Excellence

Most recently, Yuvraj was the Director of Operations, Business Development & Process Excellence at Zeon Lifesciences Ltd


Exyte completes Pharmaplan integration
Biopharma | November 28, 2025

Exyte completes Pharmaplan integration

Pharmaplan brings a pan-European footprint of locations and specialist teams, now operating within Exyte’s Biopharma & Life Sciences division


Medanta launches 550-bed super speciality hospital in Noida
Hospitals | November 28, 2025

Medanta launches 550-bed super speciality hospital in Noida

The hospital has already onboarded 200+ experienced doctors and is expected to generate 5,000–7,000 jobs


Zydus inks licensing, commercialisation pact with RK Pharma
News | November 27, 2025

Zydus inks licensing, commercialisation pact with RK Pharma

RK Pharma will manufacture and supply the finished product, while Zydus will be responsible for the NDA submission and commercialization of the product in the US


NHS’s breakthrough leukaemia therapy set to transform lives in UK
Clinical Trials | November 27, 2025

NHS’s breakthrough leukaemia therapy set to transform lives in UK

Clinical trials found that 77% of patients went into remission after receiving obe-cel